STI Study for Women
If you’ve recently tested positive for Chlamydia or Gonorrhea you may be eligible!
A research study evaluating an investigational drug, EVO100 vaginal gel, for the prevention of chlamydia and/ or gonorrhea infection in women who have been recently diagnosed with and treated for these sexually transmitted infections is enrolling at Medical Research Center of Memphis.
To qualify* you must:
- Be a woman, age 18+
- Have received a diagnosis of and may have received treatment for chlamydia and/or gonorrhea in the last 16 weeks
*Other conditions may apply
Qualified participants receive:
- Study-related medication or placebo (if you have an active infection, you will receive treatment) at no cost
- Study-related medical exams at no cost
- Compensation for time and travel
Insurance is not required to participate in this study.